CX Trademark

Trademark Overview


On Monday, December 11, 2017, a trademark application was filed for CX with the United States Patent and Trademark Office. The USPTO has given the CX trademark a serial number of 79235746. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, September 11, 2025. This trademark is owned by PACIFIC EDGE LIMITED. The CX trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:

Diagnostic biomarker reagents for medical purposes, diagnostic preparations for medical purposes, none of the foregoing for use in cell cultures

Health and medical assessment, evaluation and diagnostic services, including the prognostic and diagnostic testing of biological samples especially [ blood and ] urine, including for the prognostic and diagnostic testing, monitoring and reporting of cancer, including bladder cancer, [ gastric cancer, colorectal cancer, endometrial cancer, and melanoma, ] none of the foregoing relate to cell cultures

Medical test kits comprising medical sample tubes, medical specimen cups, absorbent pads, medical test request forms and instructions, devices, apparatuses, and analysis instruments for carrying out assays for medical purposes including prognosis, diagnosis and monitoring, none of the foregoing for use in cell cultures; medical test kits comprising medical sample tubes, medical specimen cups, absorbent pads, medical test request forms and instructions, devices, apparatuses and instruments for collection of samples for the purposes of medical prognosis, diagnosis and monitoring, none of the foregoing for use in cell cultures; [ blood ] and urine [ sampling and analysis ] systems comprising medical sample tubes, medical specimen cups, absorbent pads, medical test request forms and instructions, none of the foregoing for use in cell cultures; all of the aforementioned goods for the purpose of prognosis, diagnosis, detection or monitoring of the risk or presence of cancer, especially bladd...
cx

General Information


Serial Number79235746
Word MarkCX
Filing DateMonday, December 11, 2017
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, September 11, 2025
Registration Number5772092
Registration DateTuesday, June 11, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 26, 2019

Trademark Statements


Description of MarkThe mark consists of the stylized letters "CX" on the bottom of a shaded rectangle with two curved corners.
Goods and ServicesDiagnostic biomarker reagents for medical purposes, diagnostic preparations for medical purposes, none of the foregoing for use in cell cultures
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesHealth and medical assessment, evaluation and diagnostic services, including the prognostic and diagnostic testing of biological samples especially [ blood and ] urine, including for the prognostic and diagnostic testing, monitoring and reporting of cancer, including bladder cancer, [ gastric cancer, colorectal cancer, endometrial cancer, and melanoma, ] none of the foregoing relate to cell cultures
Goods and ServicesMedical test kits comprising medical sample tubes, medical specimen cups, absorbent pads, medical test request forms and instructions, devices, apparatuses, and analysis instruments for carrying out assays for medical purposes including prognosis, diagnosis and monitoring, none of the foregoing for use in cell cultures; medical test kits comprising medical sample tubes, medical specimen cups, absorbent pads, medical test request forms and instructions, devices, apparatuses and instruments for collection of samples for the purposes of medical prognosis, diagnosis and monitoring, none of the foregoing for use in cell cultures; [ blood ] and urine [ sampling and analysis ] systems comprising medical sample tubes, medical specimen cups, absorbent pads, medical test request forms and instructions, none of the foregoing for use in cell cultures; all of the aforementioned goods for the purpose of prognosis, diagnosis, detection or monitoring of the risk or presence of cancer, especially bladder cancer [, gastric cancer, colorectal cancer, endometrial cancer, and melanoma ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 6, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, July 6, 2018
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 6, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePACIFIC EDGE LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDunedin 9016
NZ

Party NamePACIFIC EDGE LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNZ

Party NamePACIFIC EDGE LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNZ

Trademark Events


Event DateEvent Description
Monday, July 9, 2018NON-FINAL ACTION WRITTEN
Thursday, July 5, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 6, 2018ASSIGNED TO EXAMINER
Tuesday, July 10, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, July 10, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 10, 2018NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, July 17, 2018NON-FINAL ACTION WRITTEN
Wednesday, July 18, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 2, 2018REFUSAL PROCESSED BY MPU
Thursday, August 2, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 13, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 13, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, August 18, 2018REFUSAL PROCESSED BY IB
Thursday, January 31, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 31, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 1, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 15, 2019ASSIGNED TO LIE
Tuesday, March 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 6, 2019NOTICE OF PUBLICATION
Wednesday, March 6, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 6, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, March 23, 2019NOTIFICATION PROCESSED BY IB
Wednesday, September 11, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 11, 2019REGISTERED-PRINCIPAL REGISTER
Saturday, September 21, 2019FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 20, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, September 21, 2019FINAL DISPOSITION PROCESSED
Saturday, October 12, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, October 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 20, 2022TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Thursday, October 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 20, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 31, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 5, 2025TEAS SECTION 71 & 15 RECEIVED
Friday, October 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 21, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, October 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 31, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 31, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 31, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 31, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 11, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, September 8, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 11, 2025REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, September 11, 2025NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED